Drug Pipeline

Tulmimetostat Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
3
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07190300
TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With…		 Trial sites expanded: 25 -> 29 locations
Active Studies by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT05467748 EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell… Non Small Cell Lung Cancer Recruiting
NCT07190300 TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With… Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Recruiting
Phase 1
NCT05944562 Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome Mycosis Fungoides Active, Not Recruiting
Sponsors Running Tulmimetostat Trials
VA Office of Research and Development (1) Washington University School of Medicine (1) Novartis Pharmaceuticals (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Prostate Cancer (1)
Get alerts when Tulmimetostat trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free